Find the Perfect Plan for Your Investment Journey
Latest price
52 Week Range
- - -
Next Earnings Date
-
Next Earnings Date
-
Latest price
Market Cap | €771.88K |
EV | €10.99M |
Shares Outstanding | 875.15K |
Beta | 1.17 |
Analyst Rating | NOT_AVAILABLE |
Analyst Target Price | - |
P/E 2024E | - |
P/Revenue 2024E | - |
Revenue | -26.10% |
EPS | 49.40% |
Operating Cash Flow | 15.80% |
Free Cash Flow | 36.30% |
Revenue | - |
EPS | - |
Operating Cash Flow | - |
Free Cash Flow | - |
Gross Margin 2024E | - |
Net Profit Margin 2024E | - |
ROE 2024E | - |
ROCE 2023 | - |
DPS 2024E | - |
Payout Ratio 2024E | - |
Div. Yield 2024E | - |
DPS Last 3Y CAGR | - |
Price
%
1M
3M
6M
1Y
3Y
5Y
Epigenomics AG
ECX
Sector
Industry
CEO
Data Unavailable
Employees
6
Website
www.epigenomics.comIPO Date
Headquarters
Geneststrasse 5, Berlin, Berlin, 10829, Germany
COMPANY
NEWSLETTER
© Copyright 2025, All Rights Reserved